TERT and lung cancer: The stratified analysis by cancer type associated the TERT rs2736100 polymorphism with lung cancer risk (homozygous model: OR=1.60, 95% CI=1.49–1.71, P<0.001; heterozygous model: OR=1.25, 95% CI=1.20–1.31, P=0.008; dominant model: OR=1.33, 95% CI 1.26–1.39, P<0.001; recessive model: OR=1.40, 95% CI=1.32–1.48, P<0.001; and allele contrast model: OR=1.24, 95% CI=1.17–1.31, P<0.001).